Literature DB >> 3153290

Effect of corticosteroids on coagulation factors in children with nephrotic syndrome.

N Ueda1, S Kawaguchi, Y Niinomi, T Nonoda, J Matsumoto, M Ohnishi, T Yasaki.   

Abstract

Prothrombin time (PT), activated partial thromboplastin time (APTT) and plasma procoagulant activities were studied in 38 children with nephrotic syndrome in the presence or absence of prednisolone therapy. PT was normal but APTT was prolonged during relapse in untreated patients. Increased factors V, VII, VIII, XI and XIII in both treated and untreated and factor IX in treated patients, as well as decreased factors X and XII in untreated patients, were observed during relapse. These coagulation factor changes were unrelated either to the dose of prednisolone or underlying renal histology and normalized with clinical remission. However, plasma levels of factors II, V, VIII, IX, X and XI were still increased in treated patients. The data suggest that corticosteroids shorten APTT, raise both intrinsic and extrinsic factors, and therefore have favorable and unfavorable effects on the coagulation system in children with nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3153290     DOI: 10.1007/bf00849225

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

1.  Effects of corticosteroids on coagulation of the blood.

Authors:  S OZSOYLU; H S STRAUSS; L K DIAMOND
Journal:  Nature       Date:  1962-09-22       Impact factor: 49.962

2.  Effect of prednisolone on the coagulation and fibrinolytic systems.

Authors:  S Isacson
Journal:  Scand J Haematol       Date:  1970

3.  Acquired factor IX deficiency in the nephrotic syndrome.

Authors:  E A Natelson; E C Lynch; R A Hettig; C P Alfrey
Journal:  Ann Intern Med       Date:  1970-09       Impact factor: 25.391

4.  Deficiency of Hageman factor (factor XII) in patients with the nephrotic syndrome.

Authors:  G R Honig; A Lindley
Journal:  J Pediatr       Date:  1971-04       Impact factor: 4.406

5.  Nephrotic syndrome. A hypercoagulable state.

Authors:  A G Kendall; R C Lohmann; J B Dossetor
Journal:  Arch Intern Med       Date:  1971-06

6.  Comprehensive study of haemostasis in nephrotic syndrome.

Authors:  F Panicucci; A Sagripanti; M Vispi; E Pinori; L Lecchini; G Barsotti; S Giovannetti
Journal:  Nephron       Date:  1983       Impact factor: 2.847

7.  Nephrotic syndrome and coagulation and fibrinolytic abnormalities.

Authors:  N D Vaziri
Journal:  Am J Nephrol       Date:  1983 Jan-Feb       Impact factor: 3.754

8.  Changes of coagulation factors IX, VIII, VII, X, and V in nephrotic syndrome.

Authors:  N D Vaziri; H E Branson; R Ness
Journal:  Am J Med Sci       Date:  1980 Nov-Dec       Impact factor: 2.378

9.  Coagulation studies in 45 cases of nephrotic syndrome without uremia.

Authors:  A Kanfer; D Kleinknecht; M Broyer; F Josso
Journal:  Thromb Diath Haemorrh       Date:  1970-12-31

10.  Plasma factor XIII levels in children with renal disease.

Authors:  K Yoshioka; H Miyata; Y Uraoka; S Maki
Journal:  Nephron       Date:  1981       Impact factor: 2.847

  10 in total
  8 in total

1.  Tissue factor pathway inhibitor in paediatric patients with nephrotic syndrome.

Authors:  Farida Ahmed Farid; Ahmed Abdullah Mohammed; Hanaa Mohammed Afifi; Rania Saleh Beltagi
Journal:  SAJCH       Date:  2011-12

2.  Acquired factor XI deficiency in a child with membranoproliferative glomerulonephritis.

Authors:  Meghann Pine McManus; Christopher Frantz; David Gailani
Journal:  Pediatr Blood Cancer       Date:  2011-08-17       Impact factor: 3.167

3.  Haemostatic measurements in childhood nephrotic syndrome.

Authors:  A T Elidrissy; M B Abdurrahman; H M Bahakim; M D Jones; A M Gader
Journal:  Eur J Pediatr       Date:  1991-03       Impact factor: 3.183

4.  Dexamethasone Transiently Enhances Transgene Expression in the Liver When Administered at Late-Phase Post Long-Term Adeno-Associated Virus Transduction.

Authors:  Zheng Chai; Xintao Zhang; Amanda Lee Dobbins; Richard Jude Samulski; Elizabeth P Merricks; Timothy C Nichols; Chengwen Li
Journal:  Hum Gene Ther       Date:  2022-01-06       Impact factor: 4.793

Review 5.  Arterial thrombosis in the nephrotic syndrome.

Authors:  I H Fahal; P McClelland; C R Hay; G M Bell
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401

Review 6.  Platelet abnormalities in nephrotic syndrome.

Authors:  Benedicte Eneman; Elena Levtchenko; Bert van den Heuvel; Chris Van Geet; Kathleen Freson
Journal:  Pediatr Nephrol       Date:  2015-08-13       Impact factor: 3.714

7.  Platelet functions and coagulation changes in Indian children with nephrotic syndrome.

Authors:  Aliza Mittal; Kailash Chandra Aggarwal; Sumita Saluja; Archana Aggarwal; Binit Sureka
Journal:  J Clin Diagn Res       Date:  2013-08-01

8.  Nephrotic syndrome-associated hypercoagulopathy is alleviated by both pioglitazone and glucocorticoid which target two different nuclear receptors.

Authors:  Amanda P Waller; Shipra Agrawal; Katelyn J Wolfgang; Jiro Kino; Melinda A Chanley; William E Smoyer; Bryce A Kerlin
Journal:  Physiol Rep       Date:  2020-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.